Tunç Toker

Chief Operating Officer • Galen Therapeutics

Tunç is currently the Chief Operating Officer of Galen Therapeutics, a regenerative medicine company focusing on pain prevention in CNS applications.

Prior, Tunç was the head of program management and general manager for 3 assets at Mana Therapeutics, a company focusing on allogeneic TCR based cell therapies in liquid and solid tumor applications.

Prior to Mana, Tunç was the head of SmartTrials at Foundation Medicine, helping precision oncology sponsors conduct clinical research and development with deep molecular diagnostics data.

Prior, Tunç led consulting services at ZS Associates, IQVIA and Deloitte Consulting working with biotechnology / pharmaceutical sponsors helping improve R&D and commercial operations.

Tunç’s academic background includes a MS in Biotechnology with training in advanced Immunology from the Johns Hopkins University, and an MBA and BS in Mechanical Engineering both from Duke University

Also Speaking

Chris McClain

Senior Vice President of Sales and Business Development  • Be The Match BioTherapies

Leela Paris

Vice President, Process Engineering and Manufacturing, VCGT CMC Cell Manufacturing, • Vertex Cell and Gene Therapies

Wolfgang Künnecke

Vice President of Bioanalytics • 908 Devices

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.